Reference
1. Xiao P, Guo T, Luo Y, Zhang M, Yin R. Real-world data of 14 cases of brain metastases from gestational trophoblastic neoplasia and a literature review. Archives of gynecology and obstetrics. 2021 Sep 20.
2. Maestá I, de Freitas Segalla Moreira M, Rezende-Filho J, Bianconi MI, Jankilevich G, Otero S, et al. Outcomes in the management of high-risk gestational trophoblastic neoplasia in trophoblastic disease centers in South America. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2020 Sep;30(9):1366-71.
3. Lurain JR. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. American journal of obstetrics and gynecology. 2010 Dec;203(6):531-9.
4. Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. Lancet (London, England). 2010 Aug 28;376(9742):717-29.
5. Kong Y, Yang J, Jiang F, Zhao J, Ren T, Li J, et al. Clinical characteristics and prognosis of ultra high-risk gestational trophoblastic neoplasia patients: A retrospective cohort study. Gynecologic oncology. 2017 Jul;146(1):81-6.
6. Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, et al. Diagnosis and management of gestational trophoblastic disease: 2021 update. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2021 Oct;155 Suppl 1:86-93.
7. Crawford RA, Newlands E, Rustin GJ, Holden L, A’Hern R, Bagshawe KD. Gestational trophoblastic disease with liver metastases: the Charing Cross experience. British journal of obstetrics and gynaecology. 1997 Jan;104(1):105-9.
8. Ghorani E, Kaur B, Fisher RA, Short D, Joneborg U, Carlson JW, et al. Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia. Lancet (London, England). 2017 Nov 25;390(10110):2343-5.
9. Zong L, Yang J, Wang X, Kong Y, Ren T, Zhao J, et al. Management and prognosis of patients with liver metastases from gestational trophoblastic neoplasia: a retrospective cohort study. Cancer management and research. 2018;10:557-63.
10. Xiao C, Yang J, Zhao J, Ren T, Feng F, Wan X, et al. Management and prognosis of patients with brain metastasis from gestational trophoblastic neoplasia: a 24-year experience in Peking union medical college hospital. BMC cancer. 2015 Apr 28;15:318.
11. Savage P, Kelpanides I, Tuthill M, Short D, Seckl MJ. Brain metastases in gestational trophoblast neoplasia: an update on incidence, management and outcome. Gynecologic oncology. 2015 Apr;137(1):73-6.
12. Gavanier D, Leport H, Massardier J, Abbas F, Schott AM, Hajri T, et al. Gestational trophoblastic neoplasia with brain metastasis at initial presentation: a retrospective study. International journal of clinical oncology. 2019 Feb;24(2):153-60.
13. Alazzam M, Tidy J, Osborne R, Coleman R, Hancock BW, Lawrie TA. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia. Cochrane Database Syst Rev. 2016 Jan 13;2016(1):Cd008891.
14. Soper JT. Gestational Trophoblastic Disease: Current Evaluation and Management. Obstetrics and gynecology. 2021 Feb 1;137(2):355-70.
15. Newlands ES. The management of recurrent and drug-resistant gestational trophoblastic neoplasia (GTN). Best practice & research Clinical obstetrics & gynaecology. 2003 Dec;17(6):905-23.
16. Ahamed E, Short D, North B, Savage PM, Seckl MJ. Survival of women with gestational trophoblastic neoplasia and liver metastases: is it improving? The Journal of reproductive medicine. 2012 May-Jun;57(5-6):262-9.
17. Schechter NR, Mychalczak B, Jones W, Spriggs D. Prognosis of patients treated with whole-brain radiation therapy for metastatic gestational trophoblastic disease. Gynecologic oncology. 1998 Feb;68(2):183-92.
18. Newlands ES, Holden L, Seckl MJ, McNeish I, Strickland S, Rustin GJ. Management of brain metastases in patients with high-risk gestational trophoblastic tumors. The Journal of reproductive medicine. 2002 Jun;47(6):465-71.
19. Alifrangis C, Agarwal R, Short D, Fisher RA, Sebire NJ, Harvey R, et al. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Jan 10;31(2):280-6.
20. Bolze PA, Riedl C, Massardier J, Lotz JP, You B, Schott AM, et al. Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13. American journal of obstetrics and gynecology. 2016 Mar;214(3):390.e1-8.
21. Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, et al. Update on the diagnosis and management of gestational trophoblastic disease. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2018 Oct;143 Suppl 2:79-85.
22. Jorgensen K, Roychowdhury M, da Cunha G, Kim YB, Schorge JO. Stage IV Gestational Choriocarcinoma Diagnosed in the Third Trimester. Obstetrics and gynecology. 2019 Jan;133(1):163-6.
23. Li Y, Kong Y, Wan X, Feng F, Ren T, Zhao J, et al. Results with Floxuridine, Actinomycin D, Etoposide, and Vincristine in Gestational Trophoblastic Neoplasias with International Federation of Gynecology and Obstetrics Scores ≥5. The oncologist. 2021 Dec;26(12):e2209-e16.
24. Lurain JR, Singh DK, Schink JC. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy. The Journal of reproductive medicine. 2006 Oct;51(10):767-72.
25. Jareemit N, Horowitz NS, Goldstein DP, Berkowitz RS, Elias KM. EMA vs EMACO in the treatment of gestational trophoblastic neoplasia. Gynecologic oncology. 2020 Jul;158(1):99-104.
26. Han SN, Amant F, Leunen K, Devi UK, Neven P, Vergote I. EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2012 Jun;22(5):875-80.
27. Anantharaju AA, Pallavi VR, Bafna UD, Rathod PS, R VC, K S, et al. Role of salvage therapy in chemo resistant or recurrent high-risk gestational trophoblastic neoplasm. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2019 Mar;29(3):547-53.
28. Choi MC, Oh J, Lee C. Effective anti-programmed cell death 1 treatment for chemoresistant gestational trophoblastic neoplasia. European journal of cancer (Oxford, England : 1990). 2019 Nov;121:94-7.
29. Sato A, Usui H, Shozu M. ABO blood type compatibility is not a risk factor for gestational trophoblastic neoplasia development from androgenetic complete hydatidiform moles. American journal of reproductive immunology (New York, NY : 1989). 2020 Jun;83(6):e13237.
30. Soper JT, Spillman M, Sampson JH, Kirkpatrick JP, Wolf JK, Clarke-Pearson DL. High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients. Gynecologic oncology. 2007 Mar;104(3):691-4.
31. Ngu SF, Ngan HYS. Surgery including fertility-sparing treatment of GTD. Best practice & research Clinical obstetrics & gynaecology. 2021 Jul;74:97-108.
32. Khoo SK. Clinical aspects of gestational trophoblastic disease: a review based partly on 25-year experience of a statewide registry. The Australian & New Zealand journal of obstetrics & gynaecology. 2003 Aug;43(4):280-9.
33. Lurain JR, Singh DK, Schink JC. Role of surgery in the management of high-risk gestational trophoblastic neoplasia. The Journal of reproductive medicine. 2006 Oct;51(10):773-6.
34. Neubauer NL, Latif N, Kalakota K, Marymont M, Small W, Jr., Schink JC, et al. Brain metastasis in gestational trophoblastic neoplasia: an update. The Journal of reproductive medicine. 2012 Jul-Aug;57(7-8):288-92.